🔎 Trials Near Me

Gara Jalqabaatti › Kanisa Harkaa › Wisconsin › Madison

Qorannoo klinikaalii Kanisa Harkaa Madison, WI keessatti

Qorannoo 11 Kanisa Harkaa f Madison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Namoota walitti qabaa jiraSadarkaa 2
  • UW Health Carbone Cancer Center, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, Madison
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05489211

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Wisconsin - Carbone Cancer Center, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213791

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Board of Regents of the University of Wisconsin, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07070232

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Wisconsin- Madison, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Wisconsin, Madison
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06710756

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • UW Carbone Cancer Center, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT04900818

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • University of Wisconsin, Madison
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Wax-2025 · NCT03175224

Qorannoo Kanisa Harkaa magaalota biroo keessatti

Qorannoo biroo Madison keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.